X0508 4 2026-02-20 0 0001404644 Neurogene Inc. NGNE 0001968554 Jordan Julie C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR NEW YORK NY 10011 0 1 0 0 Chief Medical Officer 0 Common Stock 2026-02-20 4 A 0 4900 0 A 13300 D Stock Option (Right to Buy) 17.64 2026-02-20 4 A 0 29600 0 A 2036-02-20 Common Stock 29600 29600 D Consist of 4,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date. Consist of (a) 8,400 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (b) 4,900 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date. This option represents the right to purchase 29,600 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date. /s/ Donna M. Cochener, as attorney-in-fact for Julie Jordan 2026-02-24